Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research
Financial Results:
Wanbury Ltd reported Revenues for Q1FY25 of ₹131.11 Crores down from ₹146.29 Crore year on year, a fall of 10.38%.
Total Expenses for Q1FY25 of ₹131.01 Crores down from ₹141.91 Crores year on year, a fall of 7.68%.
Consolidated Net Profit of ₹1.04 Crores down 77.83% from ₹4.69 Crores in the same quarter of the previous year.
The Earnings per Share is ₹0.32, down 77.62% from ₹1.43 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.